Regenxbio Inc (RGNX)

Finanzdaten der Regenxbio Inc-Aktie (RGNX)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	29.67% 15.62	22.21	28.91	19.98	19.14
Cost Of Revenue	61.89% 4.283	11.24	12.39	9.475	4.112
Gross Profit	3.32% 11.34	10.97	16.53	10.50	15.03
Operating Expenses	0.43% 75.20	74.88	81.49	83.61	81.18
Interest Income/Expense	44.75% 1.973	1.363	1.624	1.12	2.755
Benefits Costs and Expenses	7.39% 78.95	85.25	90.78	92.04	85.81
Costs And Expenses	7.70% 79.48	86.12	93.87	93.08	85.30
Depreciation and Amortization	3.58% 4.18	4.335	4.372	4.435	4.178
Operating Income/Loss	0.06% -63.86	-63.90	-64.96	-73.11	-66.16
Nonoperating Income/Loss	38.17% 0.533	0.862	3.092	1.047	-0.519
Income/Loss From Continuing Operations Before Tax	0.46% -63.33	-63.04	-61.87	-72.06	-66.68
Income/Loss From Continuing Operations After Tax	0.70% -63.33	-62.89	-61.87	-72.06	-66.68
Net Income/Loss	0.70% -63.33	-62.89	-61.87	-72.06	-66.68
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	4.68% 45.73	43.69	0.0439	0.0435	0.0435
Diluted Average Shares	4.68% 45.73	43.69	0.0439	0.0435	0.0435
Basic Earnings Per Share	2.82% -1.38	-1.42	-1.41	-1.66	-1.53
Diluted Earnings Per Share	2.82% -1.38	-1.42	-1.41	-1.66	-1.53
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-